Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0001562180-20-007249

President and CEO sold 4,500 shares at $40.00 ($180,000)

  • President and CEO acquired 4,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mills Kenneth T. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-10 Exercise or conversion : show line 1 in the form +4,500 $0.85 $3,825 245,500 D
2020-12-10 Sale : show line 2 in the form −4,500 $40.00 $180,000 241,000 D
Open-market sales · 4,500 sh · avg $40.00 · $180,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-10 Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) −4,500 75,170 D
Loading xslF345X03/primarydocument.xml…